Advanced Oncotherapy said its proton therapy system for cancer treatment had obtained ISO certification.

The certification was awarded following an audit by independent compliance group Lloyd's Register.

'This certification represents an important milestone for the company,' Advanced Oncotherapy said.

'It reflects its commitment to safety and to providing a high-quality product and shows the focus that the company has on risk-based decision making throughout the organisation.'


At 1:33pm: (LON:AVO) Advanced Oncotherapy PLC share price was +0.5p at 39p